Advertisement

Pharmacy Report

Mark Cuban's drug co. launches online pharmacy | Gilead uncovers $250M counterfeit drug scheme | 14 pharmacies with most COVID therapeutics | Pfizer antiviral works against omicron | CVS, Uber partner

January 19, 2022 BHR Newsletter Virtual Events  •  Webinars   •   Whitepapers   •   OnDemand Learning  •   Podcasts 1. Mark Cuban's drug company launches online pharmacy Full story 2. Gilead says $250M in counterfeit HIV drugs ended up with patients Full story 3. 14 pharmacies with largest supply of COVID-19…

4th shot may be less effective against omicron | CVS, Walgreens temporarily close some pharmacies on weekends | Martin Shkreli banned from drug industry | 20 hospitals tied to most 'unnecessary' care | J&J, Merck & Novo invest in health data co.

January 18, 2022 BHR Newsletter Virtual Events  •  Webinars   •   Whitepapers   •   OnDemand Learning  •   Podcasts 1. 4th shot offers less protection against omicron, Israeli study suggests Full story 2. J&J, Merck and Novo invest in health data company Full story 3. 'Pharma bro' Martin Shkreli banned from…

Staff shortages temporarily close pharmacies nationwide | Novartis eyes emergency approval for COVID antiviral | Texas hospital loses Medicare contract | Layoffs hit Pfizer sales staff | Overdose deaths surge among older adults

January 13, 2022 BHR Newsletter Virtual Events  •  Webinars   •   Whitepapers   •   OnDemand Learning  •   Podcasts 1. Staff shortages spur temporary pharmacy closures nationwide Full story 2. 7 drugs likely to hit $1B in annual revenue in the next 5 years Full story 3. Pfizer cutting sales…

CMS plans to limit coverage of Aduhelm | J&J vaccine gets new warning | CVS, Walgreens limit paid sick leave | ONC shares e-prescribing guidelines | Omicron's spread, severity: 2 new findings

January 12, 2022 BHR Newsletter Virtual Events  •  Webinars   •   Whitepapers   •   OnDemand Learning  •   Podcasts 1. CMS unveils preliminary Aduhelm coverage decision Full story 2. CVS, Walgreens limit paid sick leave for employees Full story 3. FDA adds rare bleeding risk to J&J shot side effects Full story…

Pharmacist among best, top-paying healthcare jobs for '22 | Walgreens eyes 160+ locations for VillageMD | CDC: Pfizer shot protects against MIS-C | COVID hospitalizations at record high | OptumRX: 3 drugs to watch

January 11, 2022 BHR Newsletter Virtual Events  •  Webinars   •   Whitepapers   •   OnDemand Learning  •   Podcasts 1. Pfizer to produce 120M courses of Paxlovid in 2022 Full story  2. Walgreens eyes 160+ locations for VillageMD, 100+ for Walgreens Health rollout Full story  3. 14 best-paying healthcare jobs, per…

Advertisement

Pfizer's omicron vaccine will be ready by March | Tie bonuses to vaccine equity, 65 investors urge drugmakers | 2 updates on Moderna boosters | For Midwest, worst of omicron to come: 5 forecasts | Booster rates by state

January 10, 2022 BHR Newsletter Virtual Events  •  Webinars   •   Whitepapers   •   OnDemand Learning  •   Podcasts 1. Pfizer's omicron vaccine will be ready in March, CEO says Full story 2. 65 investors urge drugmakers to tie bonuses to vaccine equity Full story 3. Doubling pace of boosters…

Pharmacists can give flu shots in any state: HHS | Pfizer booster cleared for those 12+ | CDC: Definition of fully vaccinated won't change | Amgen inks $50M AI drug discovery deal | 8 drug recalls

January 6, 2022 BHR Newsletter Virtual Events  •  Webinars   •   Whitepapers   •   OnDemand Learning  •   Podcasts 1. Pharmacists can give flu shots in states where they're not licensed, HHS says Full story 2. CDC clears boosters for 12- to 15-year-olds Full story 3. Amgen inks $50M AI drug…

Hospitals decry low supply of COVID antivirals | Walmart loses health executive | Omicron surge projected to peak in Jan. | 4th Pfizer shot sparks 5-fold antibody boost, Israeli data suggests | Mass. systems to mandate boosters

January 5, 2022 BHR Newsletter Virtual Events  •  Webinars   •   Whitepapers   •   OnDemand Learning  •   Podcasts 1. Hospitals decry scant supply of COVID-19 antivirals Full story 2. Omicron surge may peak in January, models predict Full story 3. US orders 10 million more courses of Pfizer's COVID-19 antiviral Full…

List prices for 460 drugs rose Jan. 1 | Safety alert issued for COVID antiviral | New variant found in France | Payers await Medicare decision on Aduhelm coverage | Fla. governor to US: Allow states to buy antibody drugs

January 4, 2022 BHR Newsletter Virtual Events  •  Webinars   •   Whitepapers   •   OnDemand Learning  •   Podcasts 1. List prices for 460 drugs increased Jan. 1 Full story 2. Medication safety group issues alert on COVID-19 antiviral Full story 3. Payers await Medicare preliminary decision on Aduhelm coverage Full…

Some Americans get unapproved 4th COVID shots | FDA authorizes Pfizer booster for kids 12-15 | Pa. hospital closes | NY creates regulatory framework for PBMs | 6 systems reporting antibody drug shortages

January 3, 2022 BHR Newsletter Virtual Events  •  Webinars   •   Whitepapers   •   OnDemand Learning  •   Podcasts 1. Some Americans are getting unapproved 4th COVID-19 shots Full story 2. FDA expands use of Pfizer vaccine, OKs boosters for kids 12-15 Full story 3. CMS releases guidance on healthcare worker…

Advertisement